Executive Summary: Anti-Infectives: World Market, 2nd. Ed., Vol. I: AntifungalsKalorama Information Executive SummariesMarch 1, 2007 7 Pages - SKU: KLE1467844 |
| Countries covered: Global Kalorama Information's Executive Summaries provide a comprehensive overview of the contents contained in our full-length market intelligence reports. Containing a snapshot of the overall market analysis, each Executive Summary provides a description of the scope and methodology used in the report; a summary of results including market size and market growth; a sampling of charts and graphs when available; and a brief look at the trends shaping the market. The report from which this Executive Summary is compiled is Anti-Infectives, Second Edition, Volume I: Antifungals n, and the full study abstract is as follows: Over one billion people suffer from fungal infections worldwide. Although athlete's foot, dandruff, vaginal yeast infection and fungal nail are the most common, there has been a steady increase in the incidence of more serious infections. This is partially due to the widespread use of antibiotics, which eliminate or decrease fungi-killing bacteria. Another has been the increased number of individuals with reduced immune responses caused by AIDS or the effects of chemotherapy. These are part of the factors that have lead to nearly 6-billion dollar antifungal drug industry. Anti-Infectives, Second Edition, Volume I: Antifungals is a comprehensive review of the market for anti fungal drugs. This is the first volume of Kalorama Information’s 2nd edition of its popular three-part series on anti-infective markets. The report focuses on two segments of antifungal treatment: systemic and topical. The report covers both currently marketed and late stage development antifungal products in detail. |
More Global Infectious Diseases Reports
2012 World Infectious Disease Testing Market Overview: Facilities, Test Volumes, and Sales Forecasts by Country by
Venture Planning Group
This report provides a worldwide overview of the infectious disease testing market environment, structure, size and growth. Includes estimates of the number of laboratories ...
2012 Global Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies by
Venture Planning Group
The infectious disease testing market is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers ...
Global Infectious Disease Treatment Market 2011-2014 by
Infiniti Research Limited
TechNavio’s analysts forecast the Global Infectious Disease Treatment market to grow at a CAGR of 8.1 percent over the period 2011–2014. One of the key ...
World Market for Anti-Infectives: Antifungals, Antibacterials and Antivirals (Treatments for HIV, HBV, HCV, Urinary Tract, Respiratory, Candidiasis and Other Infections) by
Kalorama Information
This Kalorama Information report – The World Market for Anti-Infectives - focuses on three key segments of treatment:
Antifungals (Allylamines, Azoles, ...
Future Infectious Disease Testing Market: Growth Opportunities, Business Strategies, Market Entry Barriers and Risks by
Venture Planning Group
The report identifies the major opportunities for infectious disease testing instrumentation, reagent kits/test panels, consumables, as well as IT and auxiliary products; proposes design criteria ...
See all reports like this >>
Related Markets
Infectious Diseases Reports
- Antibacterials Market to 2017 - Innovative Anti-Infectives that Target MDR Gram-Negative Pathogens Offer Significant Revenue Potential
- Global Infectious Disease Treatment Market 2011-2014
- World Market for Anti-Infectives: Antifungals, Antibacterials and Antivirals (Treatments for HIV, HBV, HCV, Urinary Tract, Respiratory, Candidiasis and Other Infections)
- Global Infectious Disease Market Outlook: Facilities, Test Volume, and Sales Forecasts by Country
- Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast
